Indeed, a large number of oncogenes (e.g., ERBB2, MYCN, KRAS, etc.) are amplified at the level of the genome within various tumor types and this amplification not only underlies hypermorphic expression and/or function, but also serves to differentiate the tumor cells from normal surrounding tissues. The gene discussed is ERBB2; the disease is neoplasm.